Frontiers | Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy
Advantage of fat-derived CD73 positive cells from multiple human tissues, prospective isolated mesenchymal stromal cells | Scientific Reports
Ecto-5′-Nucleotidase (CD73) Inhibits Nociception by Hydrolyzing AMP to Adenosine in Nociceptive Circuits | Journal of Neuroscience
Frontiers | Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
CD73 Antikörper PE (ABIN1176840)
Targeting CD73 to augment cancer immunotherapy - ScienceDirect
The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition | Journal of Cancer Research and Clinical Oncology
CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint | Nature Communications
Frontiers | CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
Next-IO™ Anti-CD73 Therapeutic Monoclonal Antibody Program - Creative Biolabs
Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma | World Journal of Surgical Oncology | Full Text
The cell-surface 5′-nucleotidase CD73 defines a functional T memory cell subset that declines with age - ScienceDirect
Extracellular vesicles derived from CD73 modified human umbilical cord mesenchymal stem cells ameliorate inflammation after spinal cord injury | Journal of Nanobiotechnology | Full Text
CD39/CD73: die kritischen Ziele für adenosinerge Signalwege - ACROBiosystems
CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A2B Adenosine Receptor Signaling | Journal of Neuroscience
Flow cytometry analysis of cell surface markers CD90, CD73, and CD105... | Download Scientific Diagram
Profound inhibition of CD73-dependent formation of anti-inflammatory adenosine in B cells of SLE patients - eBioMedicine
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies - ScienceDirect
Ecto‑5'‑nucleotidase (CD73) inhibits dorsal root ganglion neuronal apoptosis by promoting the Ado/cAMP/PKA/CREB pathway
Ecto‑5'‑nucleotidase (CD73) inhibits dorsal root ganglion neuronal apoptosis by promoting the Ado/cAMP/PKA/CREB pathway
CD73 Expression on Mesenchymal Stem Cells Dictates the Reparative Properties via Its Anti-Inflammatory Activity
Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation | Cancer Immunology, Immunotherapy
Cancers | Free Full-Text | Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers
IJMS | Free Full-Text | The Clinical Significance of CD73 in Cancer